Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

May 13, 2022

BUY
$8.77 - $18.29 $1.1 Million - $2.29 Million
125,000 New
125,000 $1.12 Million
Q4 2020

Feb 16, 2021

SELL
$15.44 - $24.23 $1.93 Million - $3.03 Million
-125,000 Closed
0 $0
Q2 2020

Aug 14, 2020

BUY
$29.41 - $51.23 $3.68 Million - $6.4 Million
125,000 New
125,000 $4.52 Million

Others Institutions Holding APLT

About Applied Therapeutics Inc.


  • Ticker APLT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,020,700
  • Market Cap $10.6M
  • Description
  • Applied Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel products to target cardiovascular disease, galactosemia, and diabetic complications. Its lead product candidate is AT-007 that has completed phase 1/2 for the treatment of galactosemia in healthy volunteers and adults, as well as is in pediatric clinical study...
More about APLT
Track This Portfolio

Track Kore Private Wealth LLC Portfolio

Follow Kore Private Wealth LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kore Private Wealth LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kore Private Wealth LLC with notifications on news.